B ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo therapy for infant leukemia shows hope
Disease control Recruiting nowThis study tests whether adding two targeted drugs, blinatumomab and venetoclax, to standard chemotherapy can better treat infants with a type of leukemia called ALL. About 153 infants with newly diagnosed ALL will receive these combinations to see if they improve remission rates…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
New hope for young adults with aggressive leukemia: drug combo enters human testing
Disease control Recruiting nowThis early-phase study tests whether adding venetoclax to a standard chemotherapy regimen is safe for adults aged 18-54 with a specific, high-risk form of B-cell acute lymphoblastic leukemia (Ph-Like ALL). About 24 participants will receive the combination to find the best dose a…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Promising new combo therapy targets tough leukemia in kids
Disease control Recruiting nowThis study tests a new treatment for children and young adults with a specific type of leukemia (Ph+ or Ph-like B-ALL). The treatment combines standard chemotherapy with targeted drugs (dasatinib or imatinib) and an immunotherapy drug (blinatumomab) that helps the immune system a…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Promising new combo therapy aims to beat a tough blood cancer
Disease control Recruiting nowThis study is for adults newly diagnosed with B-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma. It tests a combination of targeted immunotherapy drugs (blinatumomab and inotuzumab ozogamicin) plus standard chemotherapy to see if it works better than chemotherap…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New combo therapy aims to beat a tough blood cancer in young adults
Disease control Recruiting nowThis study tests whether adding a targeted drug called inotuzumab ozogamicin to standard chemotherapy helps young adults (ages 18-39) with a type of blood cancer called B-cell acute lymphoblastic leukemia. The drug works like a smart bomb, seeking out and killing cancer cells whi…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
Experimental CAR T-Cell therapy targets tough blood cancers
Disease control Recruiting nowThis early study tests a new type of CAR T-cell therapy for adults with blood cancers like leukemia, lymphoma, and multiple myeloma that have returned or not improved with standard treatments. The therapy uses a patient's own immune cells, modified to attack cancer cells. The mai…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
New targeted therapy could boost survival for High-Risk leukemia patients
Disease control Recruiting nowThis study tests whether adding a targeted drug called inotuzumab ozogamicin to standard chemotherapy and immunotherapy can improve outcomes for children and young adults with high-risk B-cell acute lymphoblastic leukemia (B-ALL). About 5,951 participants will receive either the …
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Can we use less blood in leukemia care? new study tests a smarter transfusion strategy
Knowledge-focused Recruiting nowThis study looks at whether giving blood transfusions only when hemoglobin drops below 7 gm/dL (instead of 9 gm/dL) is safe and maintains quality of life in adults with acute leukemia or related blood cancers who have had chemotherapy or a stem cell transplant. About 50 participa…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC